[go: up one dir, main page]

MX2009009841A - Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase. - Google Patents

Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase.

Info

Publication number
MX2009009841A
MX2009009841A MX2009009841A MX2009009841A MX2009009841A MX 2009009841 A MX2009009841 A MX 2009009841A MX 2009009841 A MX2009009841 A MX 2009009841A MX 2009009841 A MX2009009841 A MX 2009009841A MX 2009009841 A MX2009009841 A MX 2009009841A
Authority
MX
Mexico
Prior art keywords
farnesyltransferase
myeloid leukemia
acute myeloid
treatment
methods
Prior art date
Application number
MX2009009841A
Other languages
Spanish (es)
Inventor
Yixin Wang
Mitch Raponi
Hongtao Fan
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of MX2009009841A publication Critical patent/MX2009009841A/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B26—HAND CUTTING TOOLS; CUTTING; SEVERING
    • B26F—PERFORATING; PUNCHING; CUTTING-OUT; STAMPING-OUT; SEVERING BY MEANS OTHER THAN CUTTING
    • B26F1/00—Perforating; Punching; Cutting-out; Stamping-out; Apparatus therefor
    • B26F1/18—Perforating by slitting, i.e. forming cuts closed at their ends without removal of material
    • B26F1/20—Perforating by slitting, i.e. forming cuts closed at their ends without removal of material with tools carried by a rotating drum or similar support
    • G01N33/57505—
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B21—MECHANICAL METAL-WORKING WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
    • B21D—WORKING OR PROCESSING OF SHEET METAL OR METAL TUBES, RODS OR PROFILES WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
    • B21D28/00—Shaping by press-cutting; Perforating
    • B21D28/02—Punching blanks or articles with or without obtaining scrap; Notching
    • B21D28/14—Dies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B21—MECHANICAL METAL-WORKING WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
    • B21D—WORKING OR PROCESSING OF SHEET METAL OR METAL TUBES, RODS OR PROFILES WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
    • B21D37/00—Tools as parts of machines covered by this subclass
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Forests & Forestry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Shaping Metal By Deep-Drawing, Or The Like (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Un ensayo simple de expresión de dos genes, RASGRP1:APTX, con utilidad para diagnosticar una población de pacientes con leucemia mieloide aguda (AML), que tienen más probabilidad de responder a la inhibición de la farnesiltransferasa con tipifarnib (Rl115777.ZARNESTRA).A simple two-gene expression trial, RASGRP1: APTX, useful for diagnosing a population of patients with acute myeloid leukemia (AML), who are more likely to respond to the inhibition of farnesyltransferase with tipifarnib (Rl115777.ZARNESTRA).

MX2009009841A 2007-03-12 2008-03-13 Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase. MX2009009841A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89430807P 2007-03-12 2007-03-12
PCT/US2008/056636 WO2008112749A1 (en) 2007-03-12 2008-03-13 Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase

Publications (1)

Publication Number Publication Date
MX2009009841A true MX2009009841A (en) 2009-09-24

Family

ID=39759983

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009841A MX2009009841A (en) 2007-03-12 2008-03-13 Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase.

Country Status (9)

Country Link
EP (1) EP2135073A4 (en)
JP (1) JP2011512785A (en)
KR (1) KR20090113972A (en)
CN (1) CN102317772A (en)
AU (1) AU2008225130A1 (en)
BR (1) BRPI0808872A2 (en)
CA (1) CA2680909A1 (en)
MX (1) MX2009009841A (en)
WO (1) WO2008112749A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2354922B1 (en) * 2009-09-02 2012-02-07 Fundacion Institut De Recerca De L'hospital Universitari Vall D'hebron MARKERS FOR THE SELECTION OF PERSONALIZED THERAPIES FOR THE TREATMENT OF THE C�? NCER.
WO2012016021A2 (en) 2010-07-28 2012-02-02 Veridex, Llc Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors
US11559540B2 (en) 2010-07-28 2023-01-24 Janssen Pharmaceutica Nv Method of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors
CN108294839A (en) * 2018-03-08 2018-07-20 广州燃烧医疗技术开发有限公司 A kind of dental implant equipment of stabilization
CN108500114A (en) * 2018-03-08 2018-09-07 广州峥航机械设备有限公司 A kind of efficiently advanced mold design and manufacturing technology equipment
CN108339880A (en) * 2018-03-08 2018-07-31 佛山尘凡环保科技有限公司 A kind of high damping copper alloy material equipment of low cost
CN108465728A (en) * 2018-03-08 2018-08-31 佛山尘凡环保科技有限公司 A kind of high damping copper alloy material equipment
CN108326118A (en) * 2018-03-08 2018-07-27 佛山尘凡环保科技有限公司 A kind of Novel high-damping copper alloy material equipment
CN108500113A (en) * 2018-03-08 2018-09-07 广州峥航机械设备有限公司 A kind of novel die design and fabrication technology equipment
CN108500115A (en) * 2018-03-08 2018-09-07 广州拓讯安防科技有限公司 A kind of novel precise form fabrication device
CN108481435A (en) * 2018-03-08 2018-09-04 广州拓讯安防科技有限公司 A kind of precision form manufacturing device
CN108453165A (en) * 2018-03-08 2018-08-28 广州峥航机械设备有限公司 A kind of advanced mold design and manufacturing technology equipment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE373725T1 (en) * 2001-10-30 2007-10-15 Ortho Clinical Diagnostics Inc METHODS FOR DETECTING ACUTE MYELOIC LEUKEMIA
US20050003422A1 (en) * 2003-07-01 2005-01-06 Mitch Reponi Methods for assessing and treating cancer

Also Published As

Publication number Publication date
WO2008112749A1 (en) 2008-09-18
EP2135073A1 (en) 2009-12-23
JP2011512785A (en) 2011-04-28
KR20090113972A (en) 2009-11-03
CN102317772A (en) 2012-01-11
EP2135073A4 (en) 2011-09-21
AU2008225130A1 (en) 2008-09-18
CA2680909A1 (en) 2008-09-18
BRPI0808872A2 (en) 2014-11-11

Similar Documents

Publication Publication Date Title
MX2009009841A (en) Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase.
BRPI0906858B8 (en) in vitro methods to detect the presence of a cancer cell in an individual and to identify a specific tumor signature in an individual having cancer.
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
BRPI0718146A2 (en) INFUSION DEVICES AND METHODS
ES2422739T3 (en) Composition for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or GRO-, comprising UCB MSC
MX2009002936A (en) BIOMARCATORS OF THE OBJECTIVE, EFFECTIVENESS, DIAGNOSIS, AND / OR FORECAST MODULATION FOR RAF INHIBITORS.
CY1120961T1 (en) ORAL DOSAGE CONTAINERS INCLUDING ANTI-PETROLEUM PATENT AND ACID INHIBITOR
WO2010091049A3 (en) Diagnosis and treatment of cancer
EA200802213A1 (en) METHODS OF TREATING BLOOD DISEASES
CR9315A (en) METHODS AND SYSTEMS FOR DIAGNOSIS, FORECAST AND SELECTION OF THE TREATMENT OF LEUKEMIA
ATE424159T1 (en) CATHETER
EP2061907A4 (en) TCL1 EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA (LLC) REGULATED BY MIR-29 AND MIR-181
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
GB2463401B (en) Characterizing prostate disorders by analysis of microvesicles
CR20110066A (en) MONOCLONAL ANTIBODIES AGAINST THE INHIBITING TISSULAR FACTOR OF THE VIA
WO2010017515A3 (en) Breast cancer specific markers and methods of use
WO2010062960A3 (en) METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
MX2020004501A (en) THE USE OF BRUTON'S TYROSINE KINASE INHIBITORS (BTK).
MX2007004176A (en) B7-h1 and methods of diagnosis, prognosis, and treatment of cancer.
EA201101521A1 (en) METHODS OF TREATMENT OF ONCOLOGICAL DISEASES, USING EPIMETABOLIC SWITCHES, MULTIPLE-DIFFERENT INTRACELLULAR MOLECULES OR IMPACT FACTORS
ECSP10010206A (en) INHIBITORS OF THE HUMAN IMUNODEFICIENCY VIRUS REPLICATION
UY31816A (en) AGENT FOR THE TREATMENT AND / OR PREVENTION OF AN AUTOIMMUNE DISEASE AND FOR THE FORMATION OF REGULATORY CELLS
EA200801046A1 (en) NON-INVASIVE METHOD FOR IDENTIFYING TRANSITIONAL CELL CARCINOMA OF URINARY BUBBLE IN VITRO
CY1119867T1 (en) VAP-1 SUSPENSIONS FOR USE IN TREATMENT OF DISEASES
MX2009005941A (en) Companion diagnostic assays for cancer therapy.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal